Heparin Market Poised for USD 9.61 Billion Growth by 2031 Owing to Rising Prevalence of Chronic Diseases
The heparin market is driven by the increasing prevalence of chronic diseases such as cardiovascular diseases, cancer, and others. This growing demand for anticoagulant therapies